Viewing Study NCT06287268


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-01-02 @ 1:35 AM
Study NCT ID: NCT06287268
Status: RECRUITING
Last Update Posted: 2025-01-14
First Post: 2024-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Revolade Tablets Specified Drug-use Survey
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module